Clinical trial
A Phase III, Non-Inferiority, Randomized, Double-Blind, Parallel-Group, Multicentre, Single-Dose, Comparative Clinical Study of Lactase Eurofarma (Test Drug) and Lactaid® (Comparative Drug), Assessing the Efficacy and Safety in the Treatment of Patients With Lactose Intolerance (Hypolactasia)
NCT01145339 is registered in ClinicalTrials.gov with Eurofarma Laboratorios S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Non-Inferiority, Randomized, Double-Blind, Parallel-Group, Multicentre, Single-Dose, Comparative Clinical Study of Lactase Eurofarma (Test Drug) and Lactaid® (Comparative Drug), Assessing the Efficacy and Safety in the Treatment of Patients With Lactose Intolerance (Hypolactasia)
- Lead sponsor
- Eurofarma Laboratorios S.A.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- March 31, 2012
- Enrollment
- 140 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
hypolactasia